tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Evolus reports Q3 EPS (24c), consensus (18c)
PremiumThe FlyEvolus reports Q3 EPS (24c), consensus (18c)
4d ago
Evolus’s Potential Amid Market Challenges: Buy Rating Supported by Undervaluation and Growth Prospects
Premium
Ratings
Evolus’s Potential Amid Market Challenges: Buy Rating Supported by Undervaluation and Growth Prospects
17d ago
Needham medtech & diagnostics analysts hold analyst/industry conference call
Premium
The Fly
Needham medtech & diagnostics analysts hold analyst/industry conference call
1M ago
Evolus submits Evolysse premarket approval application to FDA
PremiumThe FlyEvolus submits Evolysse premarket approval application to FDA
3M ago
Evolus, Inc. Faces Financial Instability Amid Economic Uncertainty and Consumer Spending Risks
Premium
Company Announcements
Evolus, Inc. Faces Financial Instability Amid Economic Uncertainty and Consumer Spending Risks
3M ago
Evolus, Inc. Earnings Call: Mixed Sentiments and Strategic Goals
Premium
Company Announcements
Evolus, Inc. Earnings Call: Mixed Sentiments and Strategic Goals
3M ago
Evolus downgraded to Hold from Buy at Needham
PremiumThe FlyEvolus downgraded to Hold from Buy at Needham
3M ago
Evolus price target lowered to $20 from $27 at H.C. Wainwright
Premium
The Fly
Evolus price target lowered to $20 from $27 at H.C. Wainwright
3M ago
Evolus, Inc. Reports Q2 2025 Financial Results
Premium
Company Announcements
Evolus, Inc. Reports Q2 2025 Financial Results
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100